Health Monitor Liechtenstein: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Liechtenstein.

Press releases published on July 14, 2026

Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer
DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026
DBV Technologies présente ses résultats financiers du premier semestre 2026 et fait le point sur ses activités le 16 julliet 2026
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy
ORIC® Pharmaceuticals Announces Initiation of Himalayas-1 Phase 3 Trial in mCRPC Evaluating Rinzimetostat in Combination with NUBEQA® (Darolutamide), Supported by Clinical Collaboration with Bayer
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
AVITA Medical to Announce Second Quarter 2026 Financial Results
Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight
Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026
Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026
Acquisition of Own Shares
Inkoop van eigen aandelen
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
Spur Therapeutics Announces Executive Transitions
Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases
Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.